Federation des caisses Desjardins du Quebec’s Kura Oncology KURA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.2K	Hold	1,200	–	–	﹤0.01%	2321
2026 Q1	$9.76K	Hold	1,200	–	–	﹤0.01%	2332
2025 Q4	$12.5K	Buy	+1,200	New	+$12.6K	﹤0.01%	2187
2019 Q2	–	Sell	-168	Closed	-$2.79K	–	2298
2019 Q1	$2.79K	Hold	168	–	–	﹤0.01%	1896
2018 Q4	$2.36K	Hold	168	–	–	﹤0.01%	1900
2018 Q3	$2.94K	Hold	168	–	–	﹤0.01%	1962
2018 Q2	$3.06K	Hold	168	–	–	﹤0.01%	1978
2018 Q1	$3.15K	Buy	+168	New	+$3.27K	﹤0.01%	1949

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's KURA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Kura Oncology (KURA) position steady in Q2 2026 at 1,200 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

Federation des caisses Desjardins du Quebec first reported a position in KURA in Q1 2018 and has held it in 8 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Federation des caisses Desjardins du Quebec held 1,200 shares of Kura Oncology worth $13.2K as of Q2 2026.
Federation des caisses Desjardins du Quebec left its Kura Oncology share count unchanged in Q2 2026.
Kura Oncology made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2321 holding.
Federation des caisses Desjardins du Quebec first reported a position in Kura Oncology in Q1 2018 and has held it in 8 quarters since.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.